Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016
Brown B, Mitra-Majumdar M, Darrow J, Moneer O, Pham C, Avorn J, Kesselheim A. Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016. JAMA Internal Medicine 2022, 182: 1223-1226. PMID: 36190713, PMCID: PMC9531062, DOI: 10.1001/jamainternmed.2022.4226.Peer-Reviewed Original Research